$CYTK 0.54 Developing
- Date
- Jul 30, 2026
- Mentions
- 1
- Unique authors
- 1
- Sector
- biotech
- Stance
- neutral
- On card
- no
Sentiment history
bullish
neutral
mixed
bearish
line = signal
dashed = price
No sentiment history available for $CYTK yet.
Sentiment
neutral 1
Notable posts
-
neutral 21 eng
Cytokinetics $CYTK has won UK approval for MYQORZO (aficamten) to treat eligible adults with symptomatic obstructive hypertrophic cardiomyopathy.
view on X →
Only one day of history so far — the signal arc fills in as the daily job runs.